Mochida Pharmaceutical News and Activities
Presence
Mochida Pharmaceutical develops, manufactures, and sells prescription medicines, healthcare products, and medical devices. It serves hospitals, clinics, pharmacies, and consumers in Japan with treatments for chronic and specialty conditions.
Mochida Pharmaceutical products and services overview:
- Prescription medicines
- Healthcare products
- Medical devices
- Dermatology treatments
- Cardiovascular therapies
- Women health products
Revenue: ~$800 million
Employees: 1,600
Headquarters: Tokyo, Japan
Mochida Pharmaceutical is one of the...
Mochida Pharmaceutical is a company listed under the stock ticker 4534 (JP).
Executives
View the org chart displaying its 30 main executives
Most searched biographies at Mochida Pharmaceutical
- Naoyuki Mochida, President and Representative Director
- Tomoaki Sonoda, Outside Director
- Tomoo Kugisawa, Independent Director
Create your alert
to follow the executive moves at Mochida Pharmaceutical.
Pharmaceuticals
Mochida Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Mochida Pharmaceutical
Social media about Mochida Pharmaceutical
- Mochida Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Mochida Pharmaceutical on LinkedIn, X (Twitter) & YouTube
